Housey Pharmaceuticals v. Bristol-Myers Squibb Co.

Housey Pharmaceuticals v. Bristol-Myers Squibb Co.

D. Del. (2002)

Fitzpatrick client Bristol-Myers Squibb, along with its codefendants, obtained judgment of noninfringement and invalidity of Housey Pharmaceuticals biotechnology patents concerning cell based assays. Bristol-Myers Squibb and its codefendants, obtained a Markman claim construction which forced plaintiff to concede noninfringement and invalidity and to negotiate a stipulated judgment of noninfringement and invalidity.